1. 1. Chagas-Neto, T.C., Chaves, G.M., Melo, A.S., et al. (2009): Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing. J. Clin. Microbiol., 47, 1074–1081.
2. 4. Tsai, M.S., Yang, Y.L., Wang, A.H., et al. (2012): Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates. Mycopathologia, 174, 121–130.
3. 5. Rodriguez-Tudela, J.L., Diaz-Guerra, T.M., Mellado, E., et al. (2005): Susceptibility patterns and molecular identification of Trichosporon species. Antimicrob. Agents Chemother., 49, 4026–4034.
4. 6. Araujo-Ribeiro, M., Alastruey-Izquierdo, A., Gomez-Lopez, A., et al. (2008): Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital. Rev. Iberoam. Micol., 25, 221–225.
5. 7. Kumar, V., Abbas, A.K. and Aster, J.C. (2012): Inflammation and repair. p. 29–74. In Kumar, V., Abbas, A.K. and Aster, J.C. (ed.), Robbins Basic Pathology. 9th ed., W.B. Saunders Co., Philadelphia.